In our investigation into oxidative stress-related biomarkers among patients with multiple myeloma, our findings reveal a significant association between elevated levels of MDA (>4.35), NO (>38.5), decreased GSH-Px level (<59.8), diminished CAT level (<67.2), and reduced SOD level (<21.2) with multiple myeloma. This evidence concerns the gene CAT and plasma cell myeloma.